Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
programme. This post will be predominantly patient focused, playing a key role in helping to deliver cutting edge gene therapy and experimental medicine trials. The ability to implement good clinical practice
-
The Center for Molecular Bioengineering (B CUBE, https://tu-dresden.de/cmcb/bcube ) and its partner institutions, the Biotechnology Center (BIOTEC) and the Center for Regenerative Therapies (CRTD
-
the ambition of developing innovative platforms incorporating therapeutic agents (e.g., nucleic acids, small molecules, peptides), involving mRNA for gene therapy. In the context of this project, the group
-
develop and optimize cell therapy approaches for use as immunotherapeutics in induction and maintenance of tolerance as well as identify, test, and validate biomarkers in various disease models
-
, there will be the opportunity to apply these superglues to overcome challenges in gene therapy, cell therapy of cancer, vaccines for global health, green biotransformation, or in diagnostics. The project will
-
. The employee will work on improving natural killer cell-based immunotherapies for the treatment of cancer. The work will involve a variety of techniques (imaging, flow cytometry, metabolic assays, gene editing
-
investigators within the Stanford Center for Cancer Cell Therapy to test novel therapeutics in early phase clinical trials and to identify biomarkers of response and mechanisms of resistance to cancer
-
signalling and disease progression. The goal of the Oncode Accelerator Growth Fund project is to accelerate the development of new cancer therapies. In this PhD project, you will employ existing proteomic
-
involving aging, interoception, brain-gut interactions, gene therapy/gene editing, functional in-vivo brain circuit mapping and connectomics, neuroengineering (brain-computer interface, neuromodulation
-
grown out of the Centers and Institutes, including the Evelyn F. and William L. McKnight Brain Institute, the UF Genetics Institute, the Powell Gene Therapy Center, and the UF Health Cancer Center